Small Cap Pharma Stock, That Declared 1:10 Stock Split, Hit Back To Back Upper Circuit

Vivanza Biosciences Ltd hit back to back upper circuit after the company fixed March 24, 2023 as record date for stock split/sub division of shares. The stock hit upper circuit on March 13, March 9, and March 8. The stock also witnessed spurt in volume in last few days. The company has a market capitalisation of Rs 75.42 crore. It gave 1339% return. Check details below:

Vivanza Biosciences Ltd Fixed Record Date For Stock Split: According to the BSE filing of the company, "Board of Directors of the Company at its meeting held today i.e. Saturday, March 04, 2023 at Registered Office of the Company has inter alia considered and approved the Friday, March 24, 2023 Record Date for the purpose of determining eligibility of shareholders for the purpose of subdivision of one (1) Equity Share having face value of Rs.10/- (Rupees Ten) each into 10 (Ten) Equity Shares of nominal value of Rs. 1/- each in the Share Capital of the Company."

Vivanza Biosciences Ltd Stock Performance & Return: The stock's last trading price is Rs 188.55 apiece with 52-week high quoted at Rs 195.00 apiece and 52-week low is Rs 115.55 apeice, respectively. The stock gave 21% return in last 1-week, 32% return in last 1-month, 55% return in last 3-months, 15% in last 1-year, 38% in last 2-years. In last 3-years, it soared 1339%.

Vivanza Biosciences Ltd About: Headquartered in Gujarat, India, Vivanza Biosciences Limited was incorporated in April 2016 with the objective to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. Vivanza is the bridge between people, Medical Practitioners and the Patients and together we are a healthcare organization dedicated to improving the lives of people globally, according to its official website.

The stock recently fixed record date for stock split and hitting back to back upper circuit. Greynium Information Technologies and the author are not liable for any losses caused as a result of decisions based on the article. Goodreturns.in advises users to check with certified experts before taking any investment decision.